INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Oppenheimer Upgrades Inovio Pharmaceuticals (INO) to Outperform
January 25, 2024 6:57 AM ESTOppenheimer analyst Hartaj Singh upgraded Inovio Pharmaceuticals (NASDAQ: INO) from Perform to Outperform with a price target of $4.00.
The analyst comments "We hosted a call with a Key Opinion Leader (KOL) in Recurrent Respiratory Papillomatosis (RRP) and key members of the Inovio... More
